The present study aimed to investigate the effect of β‑receptor blocker propranolol on early osseointegration of pure titanium implants and the underlying molecular regulatory mechanisms. An implant osseointegration model using the tibial metaphysis of New Zealand rabbits was established. The rabbits were divided into control and low‑, medium‑ and high‑dose propranolol groups. The formation of implant osseointegration was detected by X‑ray scanning. Mesenchymal stem cells (MSCs) and osteoblasts (OBs) were isolated and cultured in vitro, isoproterenol was supplemented to simulate sympathetic action and propranolol was subsequently administrated. The effect of propranolol on cell proliferation and osteogenic differentiation were assessed by EdU, flow cytometry, alizarin red staining and alkaline phosphatase (ALP) detection. The expression levels of bone morphogenetic protein (BMP)2, RUNX family transcription factor (RunX)2, collagen (COL)‑1, osteocalcin (OCN) and β2‑adrenergic receptor (AR) were detected by immunofluorescence, reverse transcription‑quantitative PCR and western blot assay. Propranolol effectively promoted implant osseointegration in vivo, facilitated proliferation of OBs, inhibited proliferation of MSCs and enhanced osteogenic differentiation of OBs and MSCs. The calcium content and ALP activity of cells treated with propranolol were markedly higher than in the control group. Propranolol also elevated mRNA and protein expression levels of BMP2, RunX2, COL‑1 and OCN in tissue and cells, and decreased the expression of β2‑AR. The present study demonstrated that the β‑receptor blocker propranolol promoted osteogenic differentiation of OBs and MSCs and enhanced implant osseointegration. The present study provided a novel insight into the application and regulatory mechanisms of propranolol.
The stability and long‐term survival of dental implants depend not only on osseointegration, but also on complete and rigid soft tissue integration (STI) in the transgingival area. Excellent STI prevents the peri‐implant hard and soft tissues from being disturbed by bacteria and other external stimuli. However, peri‐implant STI is weaker and more susceptible to damage than natural teeth, which may increase the incidence of peri‐implant disease. The surface properties of materials in the gingival region of dental implants play a crucial role in modulating the biological response of the surrounding soft tissues. Therefore, different surface modifications have been made to enhance peri‐implant STI. This review provides an in‐depth analysis of the challenges of STI around dental implants, comprehensively reviews the effects of different implant/abutment modification strategies, including materials, surface characteristics, coatings, summarizes the availability and limitations of the current research, suggests possible future directions to provide feasible ideas for exploring the most optimal implant/abutment design to increase STI, and provides a reference for the clinical translation of the surface modifications to dental implants.
29 July 2025 in The Journal of Prosthetic Dentistry